Skip to content

Released Feb 22, 2024, after the close

10-K filed Feb 22, 2024, 53 days after period end · 0001636422-24-000016

Q4 2023 · 10-K

derived · Computed from the longer spans the company filed.

Revenue$75.08Mderived+8.6% vs Q4 2022+1.8% vs Q3 2023
Net Income-$30.31MderivedN/M vs Q4 2022N/M vs Q3 2023
EPS, diluted—Not derived. Share counts vary by quarter.
Operating Incomederived-$32,785,000N/M
Operating Cash Flowderived-$19,041,000N/M
Free Cash Flowderived-$19,296,000N/M
Margins · derived
Operating margin-43.7%+9.5 pt vs Q4 2022
Net margin-40.4%+11.4 pt vs Q4 2022

What the release said

The release

Same quarter

MetricQ4 2023derived from reported figuresQ4 2022derived from reported figuresQ4 2021derived from reported figuresQ4 2020derived from reported figures
Revenue$75.08M$69.16M$64.72M$53.28M
Net Income-$30.31M-$35.78M-$48.99M-$43.02M

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Health Catalyst, Inc. · CIK 1636422 · Engraved from SEC EDGAR